203 related articles for article (PubMed ID: 36685968)
1. Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker.
Zhou Y; Gao M; Jing Y; Wang X
Front Genet; 2022; 13():1032382. PubMed ID: 36685968
[No Abstract] [Full Text] [Related]
2. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker.
Zhao C; Liu Y; Ju S; Wang X
Int J Gen Med; 2021; 14():7411-7422. PubMed ID: 34744452
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker.
Zhou B; Gao S
Front Mol Biosci; 2021; 8():648402. PubMed ID: 33968987
[TBL] [Abstract][Full Text] [Related]
4. Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors.
Li M; Li S; Zhou L; Yang L; Wu X; Tang B; Xie S; Fang L; Zheng S; Hong T
Front Oncol; 2021; 11():717606. PubMed ID: 34604053
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
Front Genet; 2022; 13():993438. PubMed ID: 36685895
[No Abstract] [Full Text] [Related]
6. Systematic pan-cancer analysis identifies
Chen P; Yang X; Wang P; He H; Chen Y; Yu L; Fang H; Wang F; Huang Z
Ann Transl Med; 2023 Jan; 11(2):121. PubMed ID: 36819495
[TBL] [Abstract][Full Text] [Related]
7. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
Ning Y; Li Y; Wang H
Front Genet; 2023; 14():1108167. PubMed ID: 36713082
[No Abstract] [Full Text] [Related]
8. Aggresome-Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma.
Zhang Z; Zhang X; Huang A
Front Oncol; 2021; 11():718589. PubMed ID: 34485153
[TBL] [Abstract][Full Text] [Related]
9. Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3.
Wu Y; Zhang B; Nong J; Rodrìguez RA; Guo W; Liu Y; Zhao S; Wei R
Front Genet; 2023; 14():1045061. PubMed ID: 37035741
[No Abstract] [Full Text] [Related]
10. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.
Wu Y; Zhao S; Guo W; Liu Y; Requena Mullor MDM; Rodrìguez RA; Wei R
Aging (Albany NY); 2024 Jan; 16(1):129-152. PubMed ID: 38175686
[TBL] [Abstract][Full Text] [Related]
12. Pan-Cancer Analysis Based on
Zhang Y; Wang S; Han S; Feng Y
Front Oncol; 2022; 12():844794. PubMed ID: 35359375
[TBL] [Abstract][Full Text] [Related]
13. The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort.
Huang QR; Jiang Q; Tan JY; Nong RB; Yan J; Yang XW; Mo LG; Ling GY; Deng T; Gong YZ
Front Pharmacol; 2024; 15():1390615. PubMed ID: 38698811
[No Abstract] [Full Text] [Related]
14. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
[TBL] [Abstract][Full Text] [Related]
15. SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis.
Wang Y; Gu W; Wen W; Zhang X
Front Genet; 2021; 12():756094. PubMed ID: 35058967
[No Abstract] [Full Text] [Related]
16. Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy.
Zhao X; Wang Y; Jiang X; Mo B; Wang C; Tang M; Rong Y; Zhang G; Hu M; Cai H
BMC Cancer; 2023 Feb; 23(1):194. PubMed ID: 36855091
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer.
Wang M; Dai M; Wu YS; Yi Z; Li Y; Ren G
PeerJ; 2020; 8():e10128. PubMed ID: 33150070
[TBL] [Abstract][Full Text] [Related]
18. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
Huang S; Dong C; Li D; Xu Y; Wu J
Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
[No Abstract] [Full Text] [Related]
19. A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
Chen R; Wu W; Chen SY; Liu ZZ; Wen ZP; Yu J; Zhang LB; Liu Z; Zhang J; Luo P; Zeng WJ; Cheng Q
Front Immunol; 2022; 13():831542. PubMed ID: 35979347
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration.
Hu P; Zhang X; Li Y; Xu L; Qiu H
Front Genet; 2022; 13():882794. PubMed ID: 35873458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
